BiomX, Inc. Quarterly report pursuant to Section 13 or 15(d)

General (Details) - USD ($) $ in Thousands	1 Months Ended
General (Details) - USD ($) $ in Thousands	Oct. 29, 2019	Sep. 30, 2023	Dec. 31, 2022
General [Abstract]
Shares received	15,069,058
Recapitalization transaction, percentage	65.00%
Incurred accumulated deficit		$ (157,479)	$ (136,801)

Amount of accumulated undistributed earnings (deficit).